Cell biology, chemogenomics and chemoproteomics - Application to drug discovery

Expert Opinion on Drug Discovery

Volumn 2, Issue 3, 2007, Pages 381-401

  Gagna, Claude E ^a,b   Lambert, W Clark ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Alternative DNA; Cell biology; Chemical genomics; Chemical proteomics; Chemogenomics; Chemoproteomics; DNA microarrays; Multi stranded DNA; Tissue microarrays; Transitional structural chemical genomics; Transitional structural chemical proteomics; Transitional structural chemogenomics; Transitional structural chemoproteomics

Indexed keywords

CRUCIFORM DNA; DOUBLE STRANDED DNA; NUCLEIC ACID; RNA; SINGLE STRANDED DNA;

AGING; CONFORMATIONAL TRANSITION; CYTOLOGY; DNA CONFORMATION; DNA MICROARRAY; DRUG DESIGN; DRUG TARGETING; GENE EXPRESSION REGULATION; GENOME; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; STRUCTURAL GENOMICS; STRUCTURAL PROTEOMICS;

EID: 34447527789     PISSN: 17460441     EISSN: None     Source Type: Journal    
DOI: 10.1517/17460441.2.3.381     Document Type: Review

References (95)

1. HERBERT A, RICH A: The biology of left-handed Z-DNA. J. Biol. Chem. (1996) 271:11595-11598.
2. GAGNA CE, LAMBERT WC, KUO HR, FARNSWORTH PN: Localization of B-DNA and Z-DNA in terminally differentiating fiber cells in the adult lens. J. Histochem. Cytochem. (1997) 45:1511-1521.
3. BROWN BA, LOWENHAUPT K, WILBERT CM, HANLON EB, RICH A: The Za domain of the editing enzyme dsRNA adenosine deaminase binds left-handed Z-RNA as well as Z-DNA. Proc. Nad. Acad. Sci. USA (2000) 97:13531-13586.
4. SINDEN RR: DNA structure and function. Academic Press, New York (1994).
5. GAGNA CE, LAMBERT WC: The halting arrival of left-handed Z-DNA. Med. Hypotheses (2003) 60:418-423.
6. VENTER JC, ADAMS MD, MYERS EW et al.: The sequence of the human genome. Science (2001) 291:1304-1351.
7. SEHGAL A: Drug discovery and development using chemical genomics. Curr. Opin. Drug Discov. Dev. (2002) 5:526-531.
8. LOCKHART DJ, WINZELER EA: Genomics, gene expression and DNA arrays. Nature (2000) 405:827-836.
9. JEFFERY DA, BOGYO M: Chemical proteomics and its application to drug discovery Curr. Opin. Biotechnol. (2003) 14:87-95.
10. BEROZA P, VILLAR HO, WICK MM, MARTIN GR: Chemoproteomics as a basis for post-genomic drug discovery. Drug Discov. Today (2002) 7:807-814.
11. SCHREIBER SL: Chemical genetics resulting from a passion for synthetic organic chemistry. Bioorg. Med. Chem. (1998) 6:1127-1152.
12. BLAKE JF: Chemoinformatics-predicting the physicochemical properties of 'drug-like' molecules. Curr. Opin. Biotechnol. (2000) 11:104-107.
13. CARON PR, MULLICAN MD, MASHAL RD, WILSON KP, SU MS, MURCKO MA: Chemogenomic approaches to drug discovery. Curr. Opin. Chem. Biol. (2001) 5:464-470.
14. FALB D, JINDAL S: Chemical genomics: bridging the gap between the proteome and therapeutics. Curr. Opin. Drug Discov. Devel. (2002) 5:532-539.
15. ZHENG XF, CHAN TF: Chemical genomics: a systematic approach in biological research and drug discovery. Curr. Issues. Mol. Biol. (2002) 4:33-43.
16. ZHENG XFS, CHAN TF: Chemical genomics in the global study of protein functions. Drug Discov. Today (2002) 7:197-205.
17. BERTSCH M, KASSNER RJ: Selective staining of proteins with hydrophobic surface sites on a native electrophoretic gel. J. Proteome Res. (2003) 2:469-475.
18. GAGNA CE, WINOKUR D, LAMBERT WC: The use of histotechnology, histochemical and immunohistochemical nucleic acid probes to qualify and quantify cell death in single-, double-, and multiple-stranded DNA in diseased and normal tissues. Recent Res. Dev. Biophys. (2004) 3:207-233.
19. GAGNA CE, LAMBERT WC: Chemistry and the genomic revolution. The Chemist (2004) 81:21-26.
20. GAGNA CE, WINOKUR D, LAMBERT WC: Cell biology, chemogenomics and chemoproteomics. Cell Biol. Int. (2004) 28:755-764.
21. GAGNA CE, CHAN N, LAMBERT WC: The effects of DNA and protein structure on cancer gene expression. Protein Sci. (2004)13:152.
22. GAGNA CE, LAMBERT WC: Effects of nucleic acids structure on normal gene expression. J. Histochem. Cytochem. (2004) 52:S50.
23. GAGNA CE, CHAN NJ, LAMBERT WC: Characterizing changes in the structure of normal and diseased genes which regulate gene expression: transitions in helical conformations of single-, double-, triple-, and four-stranded DNA. Mol. Bial. Cell (2004) 15:445a (2466).
24. GAGNA CE, LAW S, JALAJ S, et al.: The effect of mustard gas on gene expression. FASEB J. (2004) 18:A572.
25. GAGNA CE, CHAN N, LAMBERT WC: Structural transitional chemogenomics and structural transitional chemoproteomics: two novel drug discovery approaches. FASEB J. (2005) 19:521.4.
26. GAGNA CE, CHAN NJ, SPINELLI D, LAMBERT WC: Regulation of gene expression by novel antisense technology, based on structures of DNA and RNA: structural transitional genomics (and proteomics). Biophys. J. (2005) 88:2804.
27. GARAVELLI JS, HOU Z, PATTABIRAMAN N, STEPHENS RM: The RESID database of protein structure modifications and the NRL-3D sequence-structure database. Nucleic Acids Res. (2001) 29:199-201.
28. MERRICK BA: The human proteome organization (HUPO) and environmental health. EHP Toxicogenomics (2003) 111:1-5.
29. BURGER G, PLOEM JS, GOERTYLER K: Clinical cytometry and histometry. Academic Press, New York (1987).
30. SHOTTON D: Electronic light microscopy: techniques in modern biomedical microscopy. Wiley-Liss, New York (1993).
31. MURPHY DB: Fundamentals of light microscopy and electronic imaging. Wiley-Liss, New York (2001).
32. REKHTER MD, CHEN J: Molecular analysis of complex tissues is facilitated by lazer capture microdissection: critical role of upstream tissue processing. Cell Biochem. Biophys. (2001) 35:103-113,
33. MCDONALD WH, YATES JR: Proteomic tools for cell biology: Traffic (2000) 1:747-754.
34. ALBERTS B, JOHNSON A, LEWIS J, RAFF M, ROBERTS K, WALTER P: Molecular biology of the cell. Garland Science, New York (2002).
35. MOCELLIN S, PROVENZANO M, ROSSI CR, PILATI P, NITTI D, LISE M: DNA array-based gene profiling from surgical specimen to the molecular portrait of cancer. Ann Surg (2005) 241:16-26.
36. HOPKINS AL, GROOM CR: The druggable genome. Nat. Rev. Drug Discov. (2002) 1:727-730.
37. ASHTON GH, MCGRATH JA, SOUTH AP: Strategies to identify disease genes. Drugs Today (2002) 38:235-244.
38. BREDEL M, JACOBY E: Chemogenomics: an emerging strategy for rapid target and drug discovery. Nat. Rev. Genet. (2004) 5:262-275,
39. AUSTIN CP: The completed human genome: implications for chemical biology. Curr. Opin. Chem. Biol. (2003) 7:511-515.
40. CREWS CM, SPLITTGERBER U: Chemical genetics: exploring and controlling cellular processes with chemical probes. Trends Biochem. Sci. (1999) 24:317-320.
41. RUSSELL RB, EGGLESTON DS: New roles for structure in biology and drug discovery. Nat. Struct. Biol. Suppl. (2000) 7:928-930.
42. GAGNA CE: Structural nucleic acids microarray. Biochemistry. (2001) 40: 8648.
43. HAUGLAND RP: Handbook of Fluorescent Probes. Ninth Edition. Molecular Probes, Eugene, OR (2004).
44. GILBERT DE, FEIGON J: Structural analysis of drug-DNA interactions, Curr. Opin. Struct. Biol. (1991) 1:439-445.
45. BLASZAK RT, POTAMAN V, SINDEN RR. BISSLER JJ: DNA structural transitions within the PKD1 gene. Nucleic Acids Res. (1999) 27:2610-2617.
46. PUFALL MA, LEE GM, NELSON ML et al.: Variable control of Ets- 1 DNA binding by multiple phosphates in an unstructured region. Science (2005) 309:142-145.
47. RAO PV, GONZALEZ P, PERSSON B, JORNVALL H, GARLAND D, ZIGLER S: Guinea pig and bovine ζ-crystallins have distinct functional characteristics highlighting replacements in otherwise similar structures. Biochem. (1997) 36:5353-5362.
48. CHEN JH, KANG LY: The pleiotropic role of RF-36 gene product, homeotic switch during lens growth and differentiation. In: Cellular and Molecular Aspects of Eye Research. Sino-American Technology, New York (1986) 107-113.
49. LAVERS GC, TANG JC, CHEN JH: Effect of lens protein (RF-36) isolated from cortical fiber cells on mRNA translation. In: Lavers GC, and Chen JH, editors. Cellular and Molecular Aspects of Eye Research. Sino-American Technology; New York (1988) 92-100.
50. CHEN JH, SHEN DF, TONG TC, ZHANG L, LIU HL: The pleiotropic roles of RF-36 nucleic acid binding protein: DNA topology and receptor response in crystallin gene expression. In: Papas TS, editor. Gene Regulation and AIDS: Transcriptional Activation, Retroviruses and Pathogenesis. Advances In Applied Biotechnology Series. Vol. 7. Gulf Publishers, Houston (1987) 107-121.
51. GAGNA CE, LAMBERT WC: Binding properties of bovine ocular lens ζ-crystallin to right-handed B-DNA, single-stranded
52. DNA and left-handed Z-DNA. Cell Biol. Int. (1998) 22:217-225.
53. CHEN JH, TONG TC, ZHANG L: Rapid enhancement of 'MIP' 26Da protein phosphorylation by RF-36 nucleic acid binding protein in lens cells. Lens Eye Toxic Res. (1991) 8:469-487.
54. GAGNA CE, KUO HR, AGOSTINO N et al.: Novel use of bovine ζ-crystallin as a conformational DNA probe to characterize a phase transition zone and terminally differentiating fiber cells in the adult canine ocular lens. Arch. Histol. Cytol. (2001) 64:379-391.
55. KIM CK, HAIDER KH, LIM SJ: Gene medicine: a new field of molecular medicine. Arch. Pharm. Res. (2001) 24:1-15.
56. ZARLING DA, CALHOUN CJ, HARDIN CC, ZARLING AH: Cytoplasmic Z-RNA. Proc. Natl. Acad. Sci. USA (1987) 84:6117-6121.
57. HOOS A, CORDON-CARDO C: Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations. Lab Invest. (2001) 81:1331-1338.
58. WILDSMITH SE, ELCOCK FJ. Microarrays under the microscope. Mol. Pathol. (2001) 54:8-16.
59. MOCH H, KONONEN J, KALLIONIEMI OP, SAUTER G: Tissue microarrays: what will they bring to molecular and anatomic pathology. Anat. Pathol. (2001) 8:14-20.
60. SKACEL M, SKILTON B, PETTAY JD, TUBBS RR: Tissue microarrays: a powerful tool for high-throughput analysis of clinical specimens: a review of the method with validation data. Appl. Immunohistochem. (2002) 10:1-6.
61. DAS PM, RAMACHANDRAN K, VANWERT J, SINGAL R: Chromatin immunoprecipitation assay. Biotechniques. (2004) 37:961-969.
62. ORLANDO V: Mapping chromosomal proteins in vivo by formaldehyde-cross-link ed-chromatin immunoprecipitation. Trends Biochem Sci. (2000) 25:99-104.
63. JOHNSON KD, BRESNICK EH: Dissecting long-range transcriptional mechanisms by chromatin immunoprecipitation. Methods. (2002) 26:27-36.
64. NEWMAN-GAGE: Fetal tissue banking: standards and regulatory issues. J. Hematother. (1996) 5:189-193.
65. HAIMOWITZ MD: Practical issues in tissue banking. Am. J. Clin. Pathol. (1997) 107:S75-81.
66. OOSTERHUIS JW, COEBERGH JW, VAN VEEN EB: Tumor banks: well-guarded treasures in the interest of patients. Nature (2003) 3:73-77.
67. LO KC, CHUANG WW, LAMB DJ: Stem cell research: the facts, the myths and the promises. J. Urol. (2003) 170:2453-2458.
68. COGLE CR, GUTHRIE SM, SANDERS RC, ALLEN WL, SCOTT EW, PETERSEN BE: An overview of stem cell research and regulatory issues. Mayo. Clin. Proc. (2003) 78:993-1003.
69. REYA T, MORRISON SJ, CLARKE MF, WEISSMAN IL: Stem cells, cancer, and cancer stem cells. Nature (2001) 414:105-111.
70. GAGNA CE, KUO HR, LAMBERT WC: Terminal differentiation and left-handed Z-DNA: a review. Cell Biol. Int. (1999) 23:1-5.
71. GAGNA CE, KUO HR, HORNAN C, HAMMOND I, LAMBERT WC: Use of anti-single-stranded DNA antibodies to localize and quantify denatured DNA during cell death. Cell Biol. Int. (2000) 24:657-659.
72. GAGNA CE, KUO HR, FLOREA E et al.: Comparison of apoptosis and terminal differentiation: the mammalian aging process. J. Histochem. Crytochem. (2001) 49:929-930.
73. AROSARENA O: Tissue engineering. Curr. Opin. Otolaryngol. Head Neck Surg. (2005) 13:233-241.
74. DREGER M: Proteome analysis at the level of subcellular structures. Eur. J. Biochem. (2003) 270:589-599.
75. HUBER LA, PFALLER K, VICTOR I: Organelle proteomics: implications for subcellular fractionation in proteomics. Circ. Res. (2003) 92:962-968.
76. MCKAYCS, MCLEOD JA, MURRAY GI: Laser capture microscopy. Br. Med. J. (2000) 53:64-68.
77. ELTOUM IA, SIEGAL GP, FROST AR: Microdissection of histologic sections: past, present, and future. Adv. Anat. Pathol. (2002) 9:316-322.
78. HSU FD, NIELSEN TO, ALKUSHI A et al.: Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry. Mod. Pathol. (2002) 15:1374-1380.
79. BOWTELL D, SAMBROOK J: DNA microarrays: a molecular cloning manual. Cold Spring Harbor Laboratory Press, Cold Spring, NY (2003).
80. HELL SW: Toward fluorescent nanoscopy. Nat. Biotechnol. (2003) 21:1347-1355.
81. DOMBECK DA, BLANCHARD-DESCE M, WEBB WW: Optical recording of action potentials with second-harmonic generation microscopy. J. Neurosci. (2004) 24:999-1003.
82. GEORGE N: TIRF microscopy: the evanescent wave of the future. Am. Lab (2004) 36:26-28.
83. MEEK GA, ELDER HY: Analytical and quantitative methods in microscopy. Cambridge University Press, Cambridge, UK (1977).
84. STRAUB M, LODEMANN P, HOLROYD P, JAHN R, HELL SW: Live cell imaging by multifocal multiphoton microscopy. Eur. J. Cell Biol. (2000) 79:726-734.
85. BAHLMANN K, JAKOBS S, HELL SW: 4Pi-confocal microscopy of live cells. Ultramicroscopy (2001) 87:155-164.
86. MANN SA, HAPPEL P, HOFFMANN G, DIETZEL ID: Imaging living cells with scanning ion-conductance microscopy. GIT Imaging Microsc. (2004) 6:40-42.
87. NISHIGAKI T, WOOD CD, SHIBA K, BABA SA, DARSZON A: Stroboscopic illumination using light-emitting diodes reduces phototoxicity in fluorescence cell imaging. Biotechniques. (2006) 41:191-197.
88. HIRAOKA Y, MINDEN JS, SWEDLOW JR, SEDAT JW, AGARD DA: Focal points for chromosome condensation and decondensation revealed by three-dimensional in vivo time-lapse microscopy. Nature (1989) 342:293-296.
89. LUNTE CE, SCOTT DO: Sampling living systems using microdialysis probes. Anal. Chem. (1991) 63:773-780.
90. NICASTRO D, SCHWARTZ C, PIERSON J, GAUDETTE R, PORTER ME, MCINTOSH JR: The molecular architecture of axonemes revealed by cryoelectron tomography. Science. (2006) 313:944-948.
91. SCHIFFMANN DA, DIKOVSKAYA D, APPLETON PL et al.: Open microscopy environment and findspots: integrating image informatics with quantitative multidimensional image analysis. Biotechniques. (2006) 41:199-208.
92. BAILEY DS, BONDARA, FURNESS LM: Pharmacogenomics: it's not just pharmacogenetics, Curr. Opin. Biotech. (1998) 9:595-601.
93. RUDERT F: Genomics and proteomics tools for the clinic. Curr. Opin. Mol. Ther. (2000) 2:633-642.
94. PORUBLEVA L, CHITNIS PR: Proteomics: a powerful tool in the post-genomic era. Indian J. Biochem. Biophys. (2000) 37:360-368.
95. KIM JH: Bioinformatics and genomic medicine. Genet. Med. (2002) 4:625-655.